Live feed
·
INSIDERFilingvia Quantisnow
Zynerba Pharmaceuticals Inc. logo

SEC Form 4: Rosenberger Brian was granted 22,200 shares and sold $8,499 worth of shares (6,411 units at $1.33), increasing direct ownership by 7% to 249,559 units

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Zynerba Pharmaceuticals Inc. logo
ZYNE
Zynerba Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2015
Follow ZYNEFull ZYNE profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYNE (Zynerba Pharmaceuticals Inc.) and more on Quantisnow.